TATT insider sale notice: 7,311 shares planned for 08/14/2025
Rhea-AI Filing Summary
TAT Technologies Ltd (TATT) filed a Form 144 notifying a proposed sale under Rule 144 of 7,311 ordinary shares through Oppenheimer & Co. Inc. on 08/14/2025 with an aggregate market value of $247,916.01. The shares were acquired on 05/13/2018 under an Employee Stock Option Plan and will be paid in cash upon exercise. The filing states there were 10,940,358 shares outstanding and reports no sales in the past three months. The filer certifies lack of undisclosed material adverse information and includes the standard Rule 144 sale disclosures.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice for a small block of shares; unlikely to be material to shareholders or capital structure.
The filing documents a planned disposition of 7,311 ordinary shares valued at $247,916.01, representing a vanishingly small percentage of the 10,940,358 shares outstanding. The shares were issued under an employee stock option plan and the transaction is to be executed through a broker on a specified date. From a market-impact perspective, this is a standard insider liquidity event rather than a corporate action affecting operations or capital.
TL;DR: Compliance-focused filing that affirms Rule 144 procedures and a representation of no undisclosed material information.
The notice fulfils disclosure and attestation requirements under Rule 144, including acquisition details, broker information, and a statement regarding material information. It notes no aggregated sales in the prior three months. This is a routine governance and compliance disclosure tied to insider share disposition and does not indicate management change, litigation, or regulatory action.